BCM

Burrage Capital Management Portfolio holdings

AUM $99.7M
1-Year Return 65.92%
This Quarter Return
-23.88%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$102M
AUM Growth
-$47.6M
Cap. Flow
-$6.73M
Cap. Flow %
-6.62%
Top 10 Hldgs %
57.94%
Holding
38
New
9
Increased
8
Reduced
13
Closed
7

Top Buys

1
CYTK icon
Cytokinetics
CYTK
+$3.61M
2
RGNX icon
Regenxbio
RGNX
+$3.54M
3
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
+$3.27M
4
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$3.25M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$2.11M

Top Sells

1
ARQL
Arqule Inc
ARQL
+$11.9M
2
ASND icon
Ascendis Pharma
ASND
+$6.09M
3
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$3.72M
4
USPH icon
US Physical Therapy
USPH
+$2.46M
5
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$2.29M

Sector Composition

1 Healthcare 97.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IRWD icon
26
Ironwood Pharmaceuticals
IRWD
$208M
$1.17M 1.15%
+115,899
New +$1.17M
INSM icon
27
Insmed
INSM
$30.3B
$1.01M 0.99%
+65,400
New +$1.01M
WVE icon
28
Wave Life Sciences
WVE
$1.11B
$556K 0.55%
56,699
-49,287
-47% -$483K
KDNY
29
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$363K 0.36%
27,180
– –
VIRX
30
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$280K 0.28%
19,502
+3,838
+25% +$55.1K
AUTL
31
Autolus Therapeutics
AUTL
$351M
$84K 0.08%
15,006
+1,893
+14% +$10.6K
ASND icon
32
Ascendis Pharma
ASND
$11.8B
– –
-43,775
Closed -$6.09M
SLDB icon
33
Solid Biosciences
SLDB
$428M
– –
-5,366
Closed -$358K
USPH icon
34
US Physical Therapy
USPH
$1.21B
– –
-21,500
Closed -$2.46M
DCPH
35
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-59,818
Closed -$3.72M
ABMD
36
DELISTED
Abiomed Inc
ABMD
– –
-10,138
Closed -$1.73M
DRNA
37
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-104,047
Closed -$2.29M
ARQL
38
DELISTED
Arqule Inc
ARQL
– –
-595,018
Closed -$11.9M
1
2